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Direct Measurement of Supra-Physiological Levels of 
Vitamin C (Ascorbate) in Plasma using a Nanophotometer
Bailey J. Wetherella, Jordan R. Witmerb, Brett A. Wagnerb, Juan Dub, Joseph J. Cullenb, Garry R. Buettnerb
aUniversity of Northern Iowa and bThe University of Iowa
Goal
To provide a fast, efficient, and cost effective assay 
to determine supra-physiological vitamin C 
(ascorbate) concentrations in blood.
Materials and Methods
Plasma Samples
Blood plasma samples were from subjects of clinical 
trails being conducted at The University of Iowa.  Trials 
were approved by The University of Iowa IRB and are 
listed on https://clinicaltrials.gov.  Whole blood was 
collected and centrifuged at 2000 g for 15 min.  Plasma 
was than collected and immediately analyzed or stored at 
-80 ⁰C for future analyses.
UV/Vis spectroscopy
Standard Curve
A 0.100 M ascorbate standard stock solution (10.0 mL) 
was prepared in a phosphate buffer.  The exact 
concentration of the stock solution was verified by 
absorbance at 265 nm, with an extinction coefficient of 
14,500 M-1 cm-1.  Absorbance measurements were 
collected on a Implen Nanophotometer P-330 with path 
length of 40 μm.  
Dilutions were made to make standard solutions 
concentrations of 35.0, 30.0, 25.0, 20.0, 15.0, 10.0, 5.0, 
2.5, 1.3, and 0.0 mM. A standard curve was made with 
0.0, 1.3, 2.5, 5.0, 10.0, 15.0, 20.0, 25.0, 30.0, and 35.0 
mM ascorbate that was prepared from the dilutions of the 
stock solution.
Measurements
To determine the absorbance due to ascorbate any 
absorbance from 0.0 mM was subtracted out. Samples 
were compared against a standard curve to determine 
ascorbate concentration in blood plasma.  Samples were 
measured in triplicate.
Results
Use of UV/Vis Nanophotometer yields 
reliable concentrations of ascorbate. 
A plot of the measured concentrations of ascorbate vs. the 
concentration of gravimetrically prepared standards showed linear 
correlation, Figure 1 A-B. 
• Addition of ascorbate to plasma samples showed direct 
detection of ascorbate in plasma is possible, Figure 2.
• Nanophotometer assay agrees with  older technique, Figure 3.
• A pre-infusion sample is not required to estimate plasma 
ascorbate levels, Figure 4. 
Figure 1. A robust standard curve demonstrates the potential of this 
direct approach to determine ascorbate in blood.  
(A) UV/Vis spectra of known standard solution ascorbate in buffer.  Standard 
solutions prepared gravimetrically and spectra for 0.0, 1.3, 2.5, 5.0, 10.0, 
15.0, 20.0, 25.0, 30.0, and 35.0 mM observed on Implen Nanophotometer
P-330 with path length of 40 μm. 
(B) Plot of measured concentrations of ascorbate using extinction coefficient of 
14,500 M-1 cm-1 (ordinate) vs. gravimetrically prepared standards 
(abscissa). Slope = 0.91 ± 0.02, R2 = 0.998.
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Conclusions
Direct measurement of ascorbate is possible
• A microvolume UV/Vis spectrometer, such as the 
Implen Nanophotometer P-330, can be used to 
determine supra-physiological levels of ascorbate in 
blood plasma directly without any sample processing.
High ascorbate specificity achieved
• High specificity for ascorbate was observed.  A 
coefficient of variation of about 13% was observed if a 
pre-infusion blank was available as a blank.  If the 
average blank is used the estimated coefficient of 
variation was about 20%.  Variation comes from the 
variation in the absorbance of the plasma at the same 
wavelength as ascorbate (265 nm).
Easy clinical implementation
• A microvolume UV/Vis spectrometer takes up little 
space.
• The Implen Nanophotometer P-330 requires no 
external computer and can print data directly from the 
instrument.
• The protocol is easy to follow.
• A quick assessments of ascorbate plasma 
concentrations within minutes enables rapid decision 
making in a clinical setting.
Current Use 
• The method has been deployed currently supporting 
two clinical trials addressing cancer treatment with 
high-dose ascorbate.  
Background
• High-dose ascorbate is currently being tested in 
clinical trails as an adjuvant to current standard of 
care therapies for cancer; 
• Supra-physiological concentrations of ascorbate  in 
blood, 300x to 500x normal concentrations, is the 
goal;
• Previous methods to determine the level of ascorbate 
require extensive preparation, time, and materials;
• This new assay requires: minimal sample 
preparation, less time, and fewer materials;
• The new assay has been deployed to support 
ongoing clinical trials.
Figure 2:  The method 
permits accurate 
determination of 
ascorbate in the 
complex matrix of 
human blood plasma. 
The absorbances
obtained directly from 
the Implen
Nanophotometer P-330 
vs. the known 
gravimetric standard 
show a liner relationship.
NOTE. The extinction 
coefficient of 
ascorbate in plasma is 
different than in 
phosphate buffer, 
13,000 vs. 14,500 M-1
cm-1. 
Figure 3: Direct assay 
using Implen
Nanophotometer P-330 
agrees with results 
from previous assays.  
179 samples were 
analyzed.  With a linear 
regression set to go 
through the origin a 
slope of 1.00 ± 0.01 and 
R2 = 0.78.  
Figure 4.  Ascorbate 
concentrations 
determined with “post-




differences plotted as 
residual in top plot.  
169 samples were 
analyzed for ascorbate 
concentrations. A slope 
of 0.96 ± 0.01 shows the 
ability of assay to 
estimate plasma 
ascorbate 
concentrations, even if 
no pre-infusion plasma 
sample is available 
using average blank 
instead.
